🏷

Classifications

Harrison's Chapter

ICD-O Morphology

◆

Subtypes

6

Oral Tongue SCC

Carcinoma of the anterior two-thirds (mobile portion) of the tongue. The most common oral cavity subsite, with a tendency toward early depth of invasion and nodal metastasis. Rising incidence in young patients without classic tobacco/alcohol exposure.

Floor of Mouth SCC

Carcinoma of the floor of the mouth, strongly associated with tobacco and alcohol. Close proximity to the mandible and sublingual structures often leads to early bone or muscle invasion.

Gingival/Alveolar SCC

Carcinoma of the gingiva and alveolar ridge, frequently invading the underlying mandible or maxilla; may mimic benign periodontal disease.

Buccal Mucosa SCC

Carcinoma of the inner cheek lining, strongly associated with areca (betel) nut and smokeless tobacco use, particularly in South and Southeast Asia. Often arises in a background of oral submucous fibrosis.

HPV-Independent (carcinogen-driven) OSCC

The classic and dominant molecular subtype of oral cavity SCC, driven by tobacco/alcohol/areca carcinogens with near-universal TP53 mutation and CDKN2A inactivation; p16 immunohistochemistry is typically negative.

HPV-Associated OSCC

A minority of oral cavity carcinomas harbor transcriptionally active high-risk HPV. HPV is far more common in the oropharynx; its prognostic significance at oral cavity subsites is less well established.

⚙

Pathophysiology

8

Field Cancerization and Premalignant Progression

Chronic carcinogen exposure produces a "field" of genetically altered mucosa from which multiple independent or clonally related lesions arise. Visible precursor lesions (leukoplakia, erythroplakia) showing oral epithelial dysplasia progress to invasive carcinoma through stepwise accumulation of genetic alterations.

keratinocyte CL:0000312

Downstream

TP53 Mutation and Inactivation Carcinogen-induced DNA adducts produce TP53 mutations in dysplastic epithelium

Show evidence (2 references)

PMID:37752089 SUPPORT Human Clinical

"Oral leukoplakia is a common precursor lesion of oral squamous cell carcinoma, which indicates a high potential of malignancy."

Establishes oral leukoplakia as a precursor lesion that can undergo malignant transformation to oral cavity SCC.

PMID:34071997 SUPPORT Human Clinical

"Head and neck tumors develop in mucosal precursor changes that are sometimes visible but mostly not"

Supports the field-cancerization model in which carcinomas arise from precancerous mucosal changes, including unnoticed ones.

TP53 Mutation and Inactivation

TP53 is the most frequently mutated gene in HPV-independent oral cavity SCC. Tobacco carcinogen-induced mutations inactivate p53, abolishing cell-cycle checkpoints and apoptosis in response to DNA damage and permitting clonal expansion of genetically unstable cells.

squamous epithelial cell CL:0000076

TP53 hgnc:11998

cell cycle checkpoint signaling GO:0000075 ↓ DECREASED apoptotic process GO:0006915 ↓ DECREASED

Downstream

Genomic Instability and Clonal Expansion Loss of p53-mediated DNA damage response permits accumulation of further mutations

Show evidence (1 reference)

PMID:40723400 PARTIAL Human Clinical

"The most altered signaling pathways are the PI3K/AKT/mTOR, TP53, RB, and the WNT/β-catenin pathways."

Identifies TP53 among the most frequently altered signaling pathways in oral cancer; supports TP53 involvement but not the specific loss-of-checkpoint mechanism.

CDKN2A/p16 Inactivation

CDKN2A (encoding p16INK4a) is inactivated by deletion, mutation, or promoter hypermethylation in a majority of HPV-independent oral cavity SCC. Loss of p16 removes inhibition of CDK4/6, driving RB phosphorylation and unrestrained G1/S cell-cycle progression.

CDKN2A hgnc:1787

negative regulation of G1/S transition GO:2000134 ↓ DECREASED

Downstream

Genomic Instability and Clonal Expansion Unrestrained CDK4/6 activity drives proliferation of mutant clones

Show evidence (1 reference)

PMID:40723400 PARTIAL Human Clinical

"several genes frequently affected have been identified, such as TP53, CCND1, CTTN, CDKN2A, EGFR, HRAS, PI3K, ADAM9, MGAM, SIRPB1, and FAT1"

Lists CDKN2A among genes frequently affected in oral cancer; supports CDKN2A involvement but not the specific deletion/methylation mechanism.

Genomic Instability and Clonal Expansion

Loss of p53 and p16 checkpoints, together with frequent copy-number alterations (e.g., 3q amplification including PIK3CA/SOX2/TP63, 9p loss), produces a genomically unstable, proliferative clone that constitutes invasive carcinoma.

cell population proliferation GO:0008283 ↑ INCREASED

Downstream

Invasion and Cervical Lymph Node Metastasis Genomically unstable carcinoma cells acquire invasive and metastatic capacity

Show evidence (1 reference)

PMID:40723400 SUPPORT Human Clinical

"Genomic and molecular cytogenetic analyses have revealed frequent losses at 3p, 8p, 9p, and 18q, along with gains at 3q, 7p, 8q, and 11q"

Documents the recurrent copy-number losses (including 9p, harboring CDKN2A) and gains (including 3q) that underlie genomic instability in oral cancer.

EGFR Overexpression and Proliferative Signaling

EGFR is overexpressed in the majority of oral cavity SCC and amplified in a subset. EGFR signaling activates RAS-MAPK and PI3K-AKT cascades that promote proliferation, survival, and invasion, providing the rationale for EGFR-targeted therapy.

EGFR hgnc:3236

epidermal growth factor receptor signaling pathway GO:0007173 ↑ INCREASED

Downstream

Invasion and Cervical Lymph Node Metastasis EGFR-driven proliferation and motility promote local invasion and spread

Show evidence (1 reference)

PMID:40723400 PARTIAL Human Clinical

"The knowledge of this molecular pathogenesis has not yet been translated into clinical practice, apart from the use of cetuximab, an EGFR antibody."

EGFR is the one molecular target translated into oral cancer therapy (cetuximab), reflecting the central role of EGFR signaling.

PI3K-AKT-mTOR Pathway Activation

The PI3K/AKT/mTOR pathway is among the most frequently altered signaling pathways in oral cancer, activated by PIK3CA amplification/mutation (3q26) and PTEN loss. Pathway activation drives proliferation and survival downstream of EGFR and contributes to the malignant phenotype.

PIK3CA hgnc:8975

phosphatidylinositol 3-kinase/protein kinase B signal transduction GO:0043491 ↑ INCREASED

Downstream

Invasion and Cervical Lymph Node Metastasis PI3K-AKT-mTOR survival/proliferative signaling supports tumor progression and invasion

Show evidence (1 reference)

PMID:40723400 SUPPORT Human Clinical

"The most altered signaling pathways are the PI3K/AKT/mTOR, TP53, RB, and the WNT/β-catenin pathways."

Identifies PI3K/AKT/mTOR as one of the most frequently altered signaling pathways in oral cancer.

Invasion and Cervical Lymph Node Metastasis

Oral cavity SCC invades local structures (muscle, bone, perineural spaces) and metastasizes early to the cervical lymph nodes via lymphatic spread. Epithelial-mesenchymal transition and matrix remodeling underlie invasion; depth of invasion and nodal status are key prognostic determinants.

epithelial to mesenchymal transition GO:0001837 ↑ INCREASED

Downstream

Adaptive Immune Resistance Progressive, invasive/metastatic disease establishes an immunosuppressive tumor microenvironment with PD-L1-mediated adaptive immune resistance.

Show evidence (1 reference)

PMID:42107224 SUPPORT Human Clinical

"Depth of invasion (DOI) is an important prognostic factor in oral cavity squamous cell carcinoma (OSCC) and has gained prominence after incorporation into the AJCC staging system. Although DOI correlates strongly with cervical nodal metastasis"

Confirms that invasion depth correlates strongly with cervical nodal metastasis and is a key prognostic determinant in oral cavity SCC.

Adaptive Immune Resistance

Oral cavity SCC cells upregulate the PD-L1 immune-checkpoint ligand, which engages PD-1 on tumor-infiltrating T cells to dampen anti-tumor immunity and permit immune escape, particularly in recurrent/metastatic disease. This adaptive immune resistance is the mechanistic rationale for PD-1 checkpoint-inhibitor therapy.

Negative Regulation of T Cell Mediated Immunity GO:0002710 ↑ INCREASED

Show evidence (1 reference)

PMID:34071997 SUPPORT Human Clinical

"immune checkpoint inhibitors targeting the interaction of programmed death receptor 1 (PD-1) on T-cells with the PD-1 ligand PD-L1 on cancer cells improved the survival of patients with recurrent/metastatic HNSCC"

Supports PD-1/PD-L1-mediated adaptive immune resistance as a driver of immune escape in HNSCC (including oral cavity primaries) and the basis for checkpoint-inhibitor therapy.

✶

Histopathology

2

Squamous Cell Carcinoma VERY_FREQUENT

Oral cavity carcinomas are overwhelmingly squamous cell carcinomas arising from the stratified squamous epithelium, graded by degree of differentiation (well, moderately, poorly differentiated).

Keratinizing Squamous Cell Carcinoma FREQUENT

Well- and moderately-differentiated oral cavity SCC typically shows keratinization with keratin pearls and intercellular bridges, in contrast to the nonkeratinizing morphology characteristic of HPV-driven oropharyngeal carcinoma.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

6

Cardiovascular 1

Cervical Lymphadenopathy Cervical lymphadenopathy HP:0025289

Show evidence (1 reference)

PMID:42107224 SUPPORT Human Clinical

"DOI correlates strongly with cervical nodal metastasis"

Cervical nodal metastasis (presenting as cervical lymphadenopathy) is a strong and frequent feature of oral cavity SCC linked to depth of invasion.

Digestive 1

Dysphagia Dysphagia HP:0002015

Show evidence (1 reference)

PMID:36969121 SUPPORT Human Clinical

"Oral cancers are one of the leading causes of dysphagia. Swallowing dysfunction occurs owing to the disease itself, its predisposing factors, and the treatment."

Oral cavity cancers are a leading cause of dysphagia, with swallowing dysfunction arising from the disease itself; a prospective OSCC study found 10% of patients had dysphagia at baseline before treatment.

Head and Neck 1

Non-healing Oral Ulcer Oral ulcer HP:0000155

Show evidence (1 reference)

PMID:24121907 SUPPORT Human Clinical

"The most common cause of reference was a non-healing ulcer (n=35; 28.9%) followed by oral pain"

In a clinical series of 128 oral cavity SCC patients, a non-healing ulcer was the single most common presenting complaint, supporting it as the characteristic clinical presentation.

Growth 1

Weight Loss Weight loss HP:0001824

Show evidence (1 reference)

PMID:18243771 SUPPORT Human Clinical

"The objective of this observational prospective study in patients with squamous cell carcinoma (SCC) of the oral, oropharyngeal and hypopharyngeal cavity was to look into the relation between malnutrition (>or=10% unintended weight loss within 6 months) and specific quality of life (QoL)..."

A prospective study of oral cavity SCC patients documents unintentional weight loss (>=10% within 6 months) and malnutrition, supporting weight loss as a clinical feature.

Other 2

Oral Leukoplakia Oral leukoplakia HP:0002745

Show evidence (1 reference)

PMID:37752089 SUPPORT Human Clinical

"Oral leukoplakia is a common precursor lesion of oral squamous cell carcinoma, which indicates a high potential of malignancy."

Oral leukoplakia is a common, clinically recognized precursor lesion of oral cavity SCC.

Oral Cavity Neoplasm Neoplasm of the oral cavity HP:0100649

Show evidence (1 reference)

PMID:28638553 SUPPORT Human Clinical

"Oral squamous cell carcinoma (OSCC) is the most prevalent malignant neoplasm in the oral cavity and accounts for 70% to 90% of all oral malignant neoplasms."

Oral cavity SCC is the most prevalent malignant neoplasm of the oral cavity, confirming the oral cavity neoplasm as the defining feature of the disease.

🧬

Genetic Associations

5

TP53 (Somatic Mutations)

CDKN2A (Deletion/Methylation/Mutation)

PIK3CA (Amplification/Activating Mutations)

EGFR (Amplification/Overexpression)

FAT1 (Inactivating Mutations)

Gene: FAT1 hgnc:3595

Show evidence (1 reference)

PMID:40723400 PARTIAL Human Clinical

"several genes frequently affected have been identified, such as TP53, CCND1, CTTN, CDKN2A, EGFR, HRAS, PI3K, ADAM9, MGAM, SIRPB1, and FAT1"

Identifies FAT1 among the genes frequently affected in oral cancer; the review does not provide a FAT1-specific mutation frequency, so this is recorded as a recurrent driver without a frequency claim.

💊

Medical Actions

5

Surgical Resection

Action: Definitive Surgical Resection NCIT:C154430

Wide local excision with neck dissection is the primary treatment for most resectable oral cavity SCC; adequate margins and management of cervical nodes are central to outcome.

Adjuvant Radiation Therapy

Action: radiation therapy MAXO:0000014

Postoperative radiotherapy is used for adverse pathologic features such as positive margins, extranodal extension, or multiple involved nodes.

Concurrent Cisplatin Chemoradiation

Action: radiation therapy MAXO:0000014

Agent: cisplatin CHEBI:27899

Cisplatin-based chemoradiation is used adjuvantly for high-risk features (positive margins, extranodal extension) and for selected unresectable disease.

Cetuximab

Action: Pharmacotherapy NCIT:C15986

Agent: cetuximab NCIT:C1723

The anti-EGFR monoclonal antibody cetuximab is used in combination with radiation or chemotherapy in recurrent/metastatic disease and as a platinum alternative.

Immune Checkpoint Inhibitor Therapy

Action: immunotherapy Ontology label: Immunotherapy NCIT:C15262

PD-1 inhibitors (pembrolizumab, nivolumab) are approved for recurrent or metastatic head and neck SCC, including oral cavity primaries, as monotherapy or with chemotherapy.

Mechanism Target:

INHIBITS Adaptive Immune Resistance — PD-1 blockade disrupts the PD-1/PD-L1 interaction underlying adaptive immune resistance, restoring T-cell-mediated anti-tumor immunity in recurrent/metastatic disease.

🌍

Environmental Factors

3

Tobacco Use

Cigarette smoking and smokeless (chewing) tobacco are the strongest risk factors for oral cavity SCC, with a dose-response relationship. Tobacco carcinogens (polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines) form DNA adducts driving mutations, especially in TP53.

Alcohol Consumption

Chronic alcohol use synergizes multiplicatively with tobacco. Ethanol is metabolized to acetaldehyde, a Group 1 carcinogen that damages DNA and impairs repair.

Areca (Betel) Nut Chewing

Areca nut, often combined with tobacco in betel quid, is a major risk factor for buccal mucosa SCC in South/Southeast Asia and is causally linked to oral submucous fibrosis, a premalignant condition.

Show evidence (2 references)

PMID:40457710 SUPPORT Other

"Betel-chewing-related oral squamous cell carcinoma (BCR-OSCC) has become a global health issue with increasing incidence year by year around the world."

Chinese expert consensus identifies betel (areca) chewing as a defining etiologic factor for a distinct, increasingly common form of oral cavity SCC.

PMID:38832153 SUPPORT Other

"Oral submucous fibrosis (OSMF) has a high rate of malignant transformation and is an insidious chronic inflammatory disease. Though this disorder seems to be multifactorial in origin, betel quid chewing appears to be the main etiologic factor."

Links areca/betel quid chewing to oral submucous fibrosis, the premalignant condition that progresses to oral cavity SCC.

{ }

Source YAML

click to show

name: Oral Cavity Squamous Cell Carcinoma
creation_date: "2026-06-17T00:00:00Z"
category: Complex
description: >-
  Oral cavity squamous cell carcinoma (OSCC, oral SCC) is a malignant epithelial
  tumor arising from the mucosal lining of the oral cavity, including the oral
  tongue, floor of mouth, gingiva, buccal mucosa, hard palate, and retromolar
  trigone. It is the most common malignancy of the oral cavity and a major
  subsite of head and neck squamous cell carcinoma. The dominant risk factors
  are tobacco use, alcohol consumption, and areca (betel) nut chewing, which
  together account for the majority of cases. Unlike oropharyngeal carcinoma,
  most oral cavity SCC is HPV-independent and driven by carcinogen-induced
  mutations in TP53, CDKN2A, and other genes. OSCC frequently develops from
  precursor lesions (leukoplakia, erythroplakia, oral epithelial dysplasia) and
  tends to metastasize early to the cervical lymph nodes. Prognosis depends
  strongly on tumor size, depth of invasion, and nodal status.
disease_term:
  preferred_term: oral cavity squamous cell carcinoma
  term:
    id: MONDO:0004958
    label: oral cavity squamous cell carcinoma
parents:
- head and neck squamous cell carcinoma
classifications:
  icdo_morphology:
    classification_value: Squamous Cell Carcinoma
  harrisons_chapter:
  - classification_value: ONCOLOGY_HEMATOLOGY
has_subtypes:
- name: Oral Tongue
  display_name: Oral Tongue SCC
  description: >-
    Carcinoma of the anterior two-thirds (mobile portion) of the tongue. The most
    common oral cavity subsite, with a tendency toward early depth of invasion
    and nodal metastasis. Rising incidence in young patients without classic
    tobacco/alcohol exposure.
- name: Floor of Mouth
  display_name: Floor of Mouth SCC
  description: >-
    Carcinoma of the floor of the mouth, strongly associated with tobacco and
    alcohol. Close proximity to the mandible and sublingual structures often
    leads to early bone or muscle invasion.
- name: Gingiva
  display_name: Gingival/Alveolar SCC
  description: >-
    Carcinoma of the gingiva and alveolar ridge, frequently invading the
    underlying mandible or maxilla; may mimic benign periodontal disease.
- name: Buccal Mucosa
  display_name: Buccal Mucosa SCC
  description: >-
    Carcinoma of the inner cheek lining, strongly associated with areca (betel)
    nut and smokeless tobacco use, particularly in South and Southeast Asia.
    Often arises in a background of oral submucous fibrosis.
- name: HPV-Independent
  display_name: HPV-Independent (carcinogen-driven) OSCC
  description: >-
    The classic and dominant molecular subtype of oral cavity SCC, driven by
    tobacco/alcohol/areca carcinogens with near-universal TP53 mutation and
    CDKN2A inactivation; p16 immunohistochemistry is typically negative.
- name: HPV-Associated
  display_name: HPV-Associated OSCC
  description: >-
    A minority of oral cavity carcinomas harbor transcriptionally active
    high-risk HPV. HPV is far more common in the oropharynx; its prognostic
    significance at oral cavity subsites is less well established.
environmental:
- name: Tobacco Use
  description: >-
    Cigarette smoking and smokeless (chewing) tobacco are the strongest risk
    factors for oral cavity SCC, with a dose-response relationship. Tobacco
    carcinogens (polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines)
    form DNA adducts driving mutations, especially in TP53.
  exposure_term:
    preferred_term: exposure to tobacco smoking
    term:
      id: ECTO:6000029
      label: exposure to tobacco smoking
- name: Alcohol Consumption
  description: >-
    Chronic alcohol use synergizes multiplicatively with tobacco. Ethanol is
    metabolized to acetaldehyde, a Group 1 carcinogen that damages DNA and
    impairs repair.
  exposure_term:
    preferred_term: exposure to ethanol
    term:
      id: ECTO:9000027
      label: exposure to ethanol
- name: Areca (Betel) Nut Chewing
  description: >-
    Areca nut, often combined with tobacco in betel quid, is a major risk factor
    for buccal mucosa SCC in South/Southeast Asia and is causally linked to oral
    submucous fibrosis, a premalignant condition.
  evidence:
  - reference: PMID:40457710
    reference_title: "Chinese Expert Consensus on Management of Betel-Chewing-Related Oral Squamous Cell Carcinoma."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Betel-chewing-related oral squamous cell carcinoma (BCR-OSCC) has \nbecome a global health issue with increasing incidence year by year around the \nworld."
    explanation: Chinese expert consensus identifies betel (areca) chewing as a defining etiologic factor for a distinct, increasingly common form of oral cavity SCC.
  - reference: PMID:38832153
    reference_title: "Role of Antioxidant Vitamins in Oral Submucous Fibrosis: A Narrative Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Oral submucous fibrosis (OSMF) has a high rate of malignant transformation and \nis an insidious chronic inflammatory disease. Though this disorder seems to be \nmultifactorial in origin, betel quid chewing appears to be the main etiologic \nfactor."
    explanation: Links areca/betel quid chewing to oral submucous fibrosis, the premalignant condition that progresses to oral cavity SCC.
pathophysiology:
- name: Field Cancerization and Premalignant Progression
  description: >-
    Chronic carcinogen exposure produces a "field" of genetically altered mucosa
    from which multiple independent or clonally related lesions arise. Visible
    precursor lesions (leukoplakia, erythroplakia) showing oral epithelial
    dysplasia progress to invasive carcinoma through stepwise accumulation of
    genetic alterations.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  evidence:
  - reference: PMID:37752089
    reference_title: "Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Oral leukoplakia is a common precursor lesion of oral squamous cell carcinoma, \nwhich indicates a high potential of malignancy."
    explanation: Establishes oral leukoplakia as a precursor lesion that can undergo malignant transformation to oral cavity SCC.
  - reference: PMID:34071997
    reference_title: "Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Head and neck tumors develop in mucosal precursor \nchanges that are sometimes visible but mostly not"
    explanation: Supports the field-cancerization model in which carcinomas arise from precancerous mucosal changes, including unnoticed ones.
  downstream:
  - target: TP53 Mutation and Inactivation
    description: Carcinogen-induced DNA adducts produce TP53 mutations in dysplastic epithelium
- name: TP53 Mutation and Inactivation
  description: >-
    TP53 is the most frequently mutated gene in HPV-independent oral cavity SCC.
    Tobacco carcinogen-induced mutations inactivate p53, abolishing cell-cycle
    checkpoints and apoptosis in response to DNA damage and permitting clonal
    expansion of genetically unstable cells.
  cell_types:
  - preferred_term: squamous epithelial cell
    term:
      id: CL:0000076
      label: squamous epithelial cell
  genes:
  - preferred_term: TP53
    term:
      id: hgnc:11998
      label: TP53
  biological_processes:
  - preferred_term: cell cycle checkpoint signaling
    modifier: DECREASED
    term:
      id: GO:0000075
      label: cell cycle checkpoint signaling
  - preferred_term: apoptotic process
    modifier: DECREASED
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "The most altered signaling pathways are the PI3K/AKT/mTOR, TP53, RB, and \nthe WNT/β-catenin pathways."
    explanation: Identifies TP53 among the most frequently altered signaling pathways in oral cancer; supports TP53 involvement but not the specific loss-of-checkpoint mechanism.
  downstream:
  - target: Genomic Instability and Clonal Expansion
    description: Loss of p53-mediated DNA damage response permits accumulation of further mutations
- name: CDKN2A/p16 Inactivation
  description: >-
    CDKN2A (encoding p16INK4a) is inactivated by deletion, mutation, or promoter
    hypermethylation in a majority of HPV-independent oral cavity SCC. Loss of
    p16 removes inhibition of CDK4/6, driving RB phosphorylation and unrestrained
    G1/S cell-cycle progression.
  genes:
  - preferred_term: CDKN2A
    term:
      id: hgnc:1787
      label: CDKN2A
  biological_processes:
  - preferred_term: negative regulation of G1/S transition
    modifier: DECREASED
    term:
      id: GO:2000134
      label: negative regulation of G1/S transition of mitotic cell cycle
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "several genes frequently affected have been identified, such as \nTP53, CCND1, CTTN, CDKN2A, EGFR, HRAS, PI3K, ADAM9, MGAM, SIRPB1, and FAT1"
    explanation: Lists CDKN2A among genes frequently affected in oral cancer; supports CDKN2A involvement but not the specific deletion/methylation mechanism.
  downstream:
  - target: Genomic Instability and Clonal Expansion
    description: Unrestrained CDK4/6 activity drives proliferation of mutant clones
- name: Genomic Instability and Clonal Expansion
  description: >-
    Loss of p53 and p16 checkpoints, together with frequent copy-number
    alterations (e.g., 3q amplification including PIK3CA/SOX2/TP63, 9p loss),
    produces a genomically unstable, proliferative clone that constitutes
    invasive carcinoma.
  biological_processes:
  - preferred_term: cell population proliferation
    modifier: INCREASED
    term:
      id: GO:0008283
      label: cell population proliferation
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genomic and molecular cytogenetic analyses have \nrevealed frequent losses at 3p, 8p, 9p, and 18q, along with gains at 3q, 7p, 8q, \nand 11q"
    explanation: Documents the recurrent copy-number losses (including 9p, harboring CDKN2A) and gains (including 3q) that underlie genomic instability in oral cancer.
  downstream:
  - target: Invasion and Cervical Lymph Node Metastasis
    description: Genomically unstable carcinoma cells acquire invasive and metastatic capacity
- name: EGFR Overexpression and Proliferative Signaling
  description: >-
    EGFR is overexpressed in the majority of oral cavity SCC and amplified in a
    subset. EGFR signaling activates RAS-MAPK and PI3K-AKT cascades that promote
    proliferation, survival, and invasion, providing the rationale for
    EGFR-targeted therapy.
  genes:
  - preferred_term: EGFR
    term:
      id: hgnc:3236
      label: EGFR
  biological_processes:
  - preferred_term: epidermal growth factor receptor signaling pathway
    modifier: INCREASED
    term:
      id: GO:0007173
      label: epidermal growth factor receptor signaling pathway
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "The knowledge of this molecular \npathogenesis has not yet been translated into clinical practice, apart from the \nuse of cetuximab, an EGFR antibody."
    explanation: EGFR is the one molecular target translated into oral cancer therapy (cetuximab), reflecting the central role of EGFR signaling.
  downstream:
  - target: Invasion and Cervical Lymph Node Metastasis
    description: EGFR-driven proliferation and motility promote local invasion and spread
- name: PI3K-AKT-mTOR Pathway Activation
  description: >-
    The PI3K/AKT/mTOR pathway is among the most frequently altered signaling
    pathways in oral cancer, activated by PIK3CA amplification/mutation (3q26)
    and PTEN loss. Pathway activation drives proliferation and survival
    downstream of EGFR and contributes to the malignant phenotype.
  genes:
  - preferred_term: PIK3CA
    term:
      id: hgnc:8975
      label: PIK3CA
  biological_processes:
  - preferred_term: phosphatidylinositol 3-kinase/protein kinase B signal transduction
    modifier: INCREASED
    term:
      id: GO:0043491
      label: phosphatidylinositol 3-kinase/protein kinase B signal transduction
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most altered signaling pathways are the PI3K/AKT/mTOR, TP53, RB, and \nthe WNT/β-catenin pathways."
    explanation: Identifies PI3K/AKT/mTOR as one of the most frequently altered signaling pathways in oral cancer.
  downstream:
  - target: Invasion and Cervical Lymph Node Metastasis
    description: PI3K-AKT-mTOR survival/proliferative signaling supports tumor progression and invasion
- name: Invasion and Cervical Lymph Node Metastasis
  description: >-
    Oral cavity SCC invades local structures (muscle, bone, perineural spaces)
    and metastasizes early to the cervical lymph nodes via lymphatic spread.
    Epithelial-mesenchymal transition and matrix remodeling underlie invasion;
    depth of invasion and nodal status are key prognostic determinants.
  biological_processes:
  - preferred_term: epithelial to mesenchymal transition
    modifier: INCREASED
    term:
      id: GO:0001837
      label: epithelial to mesenchymal transition
  evidence:
  - reference: PMID:42107224
    reference_title: "Dissociating recurrence risk from mortality: a 10 year analysis challenging the independent prognostic value of depth of invasion in oral cavity squamous cell carcinoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Depth of invasion (DOI) is an important prognostic factor in oral cavity \nsquamous cell carcinoma (OSCC) and has gained prominence after incorporation \ninto the AJCC staging system. Although DOI correlates strongly with cervical \nnodal metastasis"
    explanation: Confirms that invasion depth correlates strongly with cervical nodal metastasis and is a key prognostic determinant in oral cavity SCC.
  downstream:
  - target: Adaptive Immune Resistance
    description: >-
      Progressive, invasive/metastatic disease establishes an immunosuppressive
      tumor microenvironment with PD-L1-mediated adaptive immune resistance.
- name: Adaptive Immune Resistance
  conforms_to: immune_checkpoint_blockade#Adaptive Immune Resistance
  description: >-
    Oral cavity SCC cells upregulate the PD-L1 immune-checkpoint ligand, which
    engages PD-1 on tumor-infiltrating T cells to dampen anti-tumor immunity and
    permit immune escape, particularly in recurrent/metastatic disease. This
    adaptive immune resistance is the mechanistic rationale for PD-1
    checkpoint-inhibitor therapy.
  biological_processes:
  - preferred_term: Negative Regulation of T Cell Mediated Immunity
    modifier: INCREASED
    term:
      id: GO:0002710
      label: negative regulation of T cell mediated immunity
  evidence:
  - reference: PMID:34071997
    reference_title: "Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "immune checkpoint inhibitors targeting the interaction of programmed death receptor 1 (PD-1) on T-cells with the PD-1 ligand PD-L1 on cancer cells improved the survival of patients with recurrent/metastatic HNSCC"
    explanation: >-
      Supports PD-1/PD-L1-mediated adaptive immune resistance as a driver of
      immune escape in HNSCC (including oral cavity primaries) and the basis for
      checkpoint-inhibitor therapy.
histopathology:
- name: Squamous Cell Carcinoma
  finding_term:
    preferred_term: Squamous Cell Carcinoma
    term:
      id: NCIT:C2929
      label: Squamous Cell Carcinoma
  frequency: VERY_FREQUENT
  description: >-
    Oral cavity carcinomas are overwhelmingly squamous cell carcinomas arising
    from the stratified squamous epithelium, graded by degree of differentiation
    (well, moderately, poorly differentiated).
- name: Keratinizing Squamous Cell Carcinoma
  finding_term:
    preferred_term: Keratinizing Squamous Cell Carcinoma
    term:
      id: NCIT:C4105
      label: Keratinizing Squamous Cell Carcinoma
  subtype: HPV-Independent
  frequency: FREQUENT
  description: >-
    Well- and moderately-differentiated oral cavity SCC typically shows
    keratinization with keratin pearls and intercellular bridges, in contrast to
    the nonkeratinizing morphology characteristic of HPV-driven oropharyngeal
    carcinoma.
phenotypes:
- category: Head and Neck
  name: Non-healing Oral Ulcer
  diagnostic: true
  description: >-
    A persistent, non-healing ulcer of the oral mucosa is the most common
    presentation, often arising from a precursor lesion.
  phenotype_term:
    preferred_term: Oral ulcer
    term:
      id: HP:0000155
      label: Oral ulcer
  evidence:
  - reference: PMID:24121907
    reference_title: "A clinical-pathological and survival study of oral squamous cell carcinomas from a population of the North of Portugal."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most common cause of reference was a non-healing ulcer \n(n=35; 28.9%) followed by oral pain"
    explanation: In a clinical series of 128 oral cavity SCC patients, a non-healing ulcer was the single most common presenting complaint, supporting it as the characteristic clinical presentation.
- category: Head and Neck
  name: Oral Leukoplakia
  description: >-
    White mucosal patches that cannot be scraped off, representing a common
    premalignant lesion of oral cavity SCC.
  phenotype_term:
    preferred_term: Oral leukoplakia
    term:
      id: HP:0002745
      label: Oral leukoplakia
  evidence:
  - reference: PMID:37752089
    reference_title: "Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Oral leukoplakia is a common precursor lesion of oral squamous cell carcinoma, \nwhich indicates a high potential of malignancy."
    explanation: Oral leukoplakia is a common, clinically recognized precursor lesion of oral cavity SCC.
- category: Neoplasm
  name: Oral Cavity Neoplasm
  description: >-
    A neoplasm arising in the oral cavity, the defining feature of the disease.
  phenotype_term:
    preferred_term: Neoplasm of the oral cavity
    term:
      id: HP:0100649
      label: Neoplasm of the oral cavity
  evidence:
  - reference: PMID:28638553
    reference_title: "A review of 640 Oral squamous cell carcinoma cases in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Oral squamous cell carcinoma (OSCC) is the most prevalent malignant \nneoplasm in the oral cavity and accounts for 70% to 90% of all oral malignant \nneoplasms."
    explanation: Oral cavity SCC is the most prevalent malignant neoplasm of the oral cavity, confirming the oral cavity neoplasm as the defining feature of the disease.
- category: Head and Neck
  name: Cervical Lymphadenopathy
  description: >-
    Enlarged cervical lymph nodes from regional metastasis, frequently present
    at diagnosis and a key prognostic factor.
  phenotype_term:
    preferred_term: Cervical lymphadenopathy
    term:
      id: HP:0025289
      label: Cervical lymphadenopathy
  evidence:
  - reference: PMID:42107224
    reference_title: "Dissociating recurrence risk from mortality: a 10 year analysis challenging the independent prognostic value of depth of invasion in oral cavity squamous cell carcinoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "DOI correlates strongly with cervical \nnodal metastasis"
    explanation: Cervical nodal metastasis (presenting as cervical lymphadenopathy) is a strong and frequent feature of oral cavity SCC linked to depth of invasion.
- category: Head and Neck
  name: Dysphagia
  description: >-
    Difficulty swallowing from tumor bulk, pain, or impaired tongue mobility.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:36969121
    reference_title: "Evaluation of swallowing in patients with T3/T4 oral squamous cell carcinoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Oral cancers are one of the leading \ncauses of dysphagia. Swallowing dysfunction occurs owing to the disease itself, \nits predisposing factors, and the treatment."
    explanation: Oral cavity cancers are a leading cause of dysphagia, with swallowing dysfunction arising from the disease itself; a prospective OSCC study found 10% of patients had dysphagia at baseline before treatment.
- category: Constitutional
  name: Weight Loss
  description: >-
    Unintentional weight loss from dysphagia, pain, and cancer cachexia,
    indicating more advanced disease.
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
  evidence:
  - reference: PMID:18243771
    reference_title: "A prospective study on malnutrition and quality of life in patients with head and neck cancer."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The objective of this observational prospective study in patients with squamous \ncell carcinoma (SCC) of the oral, oropharyngeal and hypopharyngeal cavity was to \nlook into the relation between malnutrition (>or=10% unintended weight loss \nwithin 6 months) and specific quality of life (QoL) parameters longitudinally."
    explanation: A prospective study of oral cavity SCC patients documents unintentional weight loss (>=10% within 6 months) and malnutrition, supporting weight loss as a clinical feature.
genetic:
- name: TP53
  association: Somatic Mutations
  subtype: HPV-Independent
  notes: >-
    TP53 is mutated in the large majority of HPV-independent oral cavity SCC,
    typically inactivating missense mutations with a tobacco carcinogen signature.
- name: CDKN2A
  association: Deletion/Methylation/Mutation
  subtype: HPV-Independent
  notes: >-
    CDKN2A (p16) is inactivated in a majority of cases via deletion, promoter
    hypermethylation, or point mutation.
- name: PIK3CA
  association: Amplification/Activating Mutations
  notes: >-
    PIK3CA, on the frequently amplified 3q26 region, is activated in a subset of
    oral cavity SCC, driving PI3K/AKT/mTOR signaling.
- name: EGFR
  association: Amplification/Overexpression
  notes: >-
    EGFR overexpression is common and provides the rationale for EGFR-targeted
    therapy (cetuximab).
- name: FAT1
  gene_term:
    preferred_term: FAT1
    term:
      id: hgnc:3595
      label: FAT1
  association: Inactivating Mutations
  notes: >-
    FAT1, an atypical cadherin and Hippo/Wnt pathway regulator, is among the
    genes recurrently affected in oral cavity SCC; its loss of function
    contributes to dysregulated proliferative signaling.
  evidence:
  - reference: PMID:40723400
    reference_title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: "several genes frequently affected have been identified, such as \nTP53, CCND1, CTTN, CDKN2A, EGFR, HRAS, PI3K, ADAM9, MGAM, SIRPB1, and FAT1"
    explanation: >-
      Identifies FAT1 among the genes frequently affected in oral cancer; the
      review does not provide a FAT1-specific mutation frequency, so this is
      recorded as a recurrent driver without a frequency claim.
treatments:
- name: Surgical Resection
  description: >-
    Wide local excision with neck dissection is the primary treatment for most
    resectable oral cavity SCC; adequate margins and management of cervical nodes
    are central to outcome.
  treatment_term:
    preferred_term: Definitive Surgical Resection
    term:
      id: NCIT:C154430
      label: Definitive Surgical Resection
- name: Adjuvant Radiation Therapy
  description: >-
    Postoperative radiotherapy is used for adverse pathologic features such as
    positive margins, extranodal extension, or multiple involved nodes.
  treatment_term:
    preferred_term: radiation therapy
    term:
      id: MAXO:0000014
      label: radiation therapy
- name: Concurrent Cisplatin Chemoradiation
  description: >-
    Cisplatin-based chemoradiation is used adjuvantly for high-risk features
    (positive margins, extranodal extension) and for selected unresectable disease.
  treatment_term:
    preferred_term: radiation therapy
    term:
      id: MAXO:0000014
      label: radiation therapy
    therapeutic_agent:
    - preferred_term: cisplatin
      term:
        id: CHEBI:27899
        label: cisplatin
- name: Cetuximab
  description: >-
    The anti-EGFR monoclonal antibody cetuximab is used in combination with
    radiation or chemotherapy in recurrent/metastatic disease and as a platinum
    alternative.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: cetuximab
      term:
        id: NCIT:C1723
        label: Cetuximab
- name: Immune Checkpoint Inhibitor Therapy
  description: >-
    PD-1 inhibitors (pembrolizumab, nivolumab) are approved for recurrent or
    metastatic head and neck SCC, including oral cavity primaries, as monotherapy
    or with chemotherapy.
  treatment_term:
    preferred_term: immunotherapy
    term:
      id: NCIT:C15262
      label: Immunotherapy
  target_mechanisms:
  - target: Adaptive Immune Resistance
    treatment_effect: INHIBITS
    description: >-
      PD-1 blockade disrupts the PD-1/PD-L1 interaction underlying adaptive
      immune resistance, restoring T-cell-mediated anti-tumor immunity in
      recurrent/metastatic disease.
datasets: []
references:
- reference: PMID:40723400
  title: "Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment."
- reference: PMID:37752089
  title: "Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside."
- reference: PMID:42107224
  title: "Dissociating recurrence risk from mortality: a 10 year analysis challenging the independent prognostic value of depth of invasion in oral cavity squamous cell carcinoma."
- reference: PMID:24121907
  title: "A clinical-pathological and survival study of oral squamous cell carcinomas from a population of the North of Portugal."
- reference: PMID:28638553
  title: "A review of 640 Oral squamous cell carcinoma cases in Nigeria."
- reference: PMID:36969121
  title: "Evaluation of swallowing in patients with T3/T4 oral squamous cell carcinoma."
- reference: PMID:18243771
  title: "A prospective study on malnutrition and quality of life in patients with head and neck cancer."

📚

References & Deep Research